Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
53.57
+1.86 (3.60%)
At close: Feb 27, 2026, 4:00 PM EST
53.68
+0.11 (0.21%)
After-hours: Feb 27, 2026, 7:59 PM EST

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Product Sales Revenue
1.82B3.11B
Product Sales Revenue Growth
-41.52%-53.40%
Grant Revenue
22.00M37.00M
Grant Revenue Growth
-40.54%-60.64%
Collaboration Revenue
13.00M48.00M
Collaboration Revenue Growth
-72.92%-42.17%
Licensing and Royalty Revenue
11.00M42.00M
Licensing and Royalty Revenue Growth
-73.81%-
Stand-Ready Manufacturing Revenue
80.00M-
Revenue (Total)
1.94B3.24B
Revenue (Total) Growth
-39.93%-52.74%
Updated Feb 13, 2026. Data Source: Fiscal.ai.